We have interviewed Luisa Lopes, the Leader of the Neurobiology of Ageing & Disease group at the Institute of Molecular Medicine (iMM) in Lisbon. In this short interview, Luisa talks about her research. She shares her opinion about the FDA approved Aduhelm (aducanumab) and how COVID-19 neurological complications are being addressed.
Estamos a organizar a sessão científica intitulada “Como podem os CoLABs apoiar os desafios da Saúde Global?” https://lnkd.in/dnDVwafm Juntem-se a nós no próximo dia 4 de Julho, 11h30-13h30 Visitem-nos no nosso stand!
The European Pharmaceutical Association representing Small and Medium Sized Pharmaceutical Companies. Europharm’s mission is to support and defend the interests of SMEs, in order to enhance their competitiveness and entrepreneurship within the global framework of the pharmaceutical industry. Europharm SMC is a unique business network of pharmaceutical SMEs coming from all European countries who share this common goal. The […]
O Health Cluster Portugal conta com um novo Associado / The Health Cluster Portugal has a new Member: VectorB2B – Drug Development https://lnkd.in/dBafiV6N hashtag#healthclusterportugal hashtag#healthportugal
Office:
Avenida da Liberdade, 258, 6º
1250-149 Lisboa, Portugal
+351 210 976 863
© 2025 digital connection | All rights reserved | Privacy policy| Data Privacy Contact Form
